WallStreetZenWallStreetZen

NASDAQ: CLSD
Clearside Biomedical Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Clearside Biomedical revenue was $1.66M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $306.0k, down 70.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CLSD annual revenue was $1.7M, with -79.8% growth year-over-year.

CLSD past revenue growth

How has CLSD's revenue growth performed historically?

Company
-79.77%
Industry
511.06%
Market
20.87%
CLSD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLSD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CLSD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CLSD revenue history

Current Revenue
$1.7M
Current Earnings
-$34.4M
Current Profit Margin
-2,064.4%

Be the first to know when CLSD announces revenue.

CLSD Revenue History By Year

CLSD Yearly RevenueCLSD RevenueCLSD ChangeCLSD Revenue Growth
2024-12-31$1.66M-$6.56M-79.77%
2023-12-31$8.23M$6.90M+519.89%
2022-12-31$1.33M-$28.25M-95.51%
2021-12-31$29.58M$21.68M+274.65%
2020-12-31$7.89M$5.72M+263.28%
2019-12-31$2.17M$2.14M+7,143.33%
2018-12-31$30.00k-$315.00k-91.30%
2017-12-31$345.00k-$175.00k-33.65%
2016-12-31$520.00kN/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A

1 of 1

Clearside Biomedical Revenue FAQ

What was CLSD's revenue last quarter?

On Invalid Date, Clearside Biomedical (NASDAQ: CLSD) reported Q4 2024 revenue of $306.00 thousand up 95.18% year over year. In the same quarter last year, Clearside Biomedical's revenue was $6.35 million.

What was Clearside Biomedical's revenue in 2024?

Clearside Biomedical's annual revenue for the twelve months ending Dec 31, 2024 was $1.66 million, a 79.77% decrease year over year.

How much does Clearside Biomedical make in a day?

Based on Clearside Biomedical annual revenue for the past five years, CLSD makes an average of $26,677.26 per day.

What was Clearside Biomedical's annual revenue growth in the past year?

As of Q2 2025, Clearside Biomedical's revenue has grown -79.77% year over year. This is 590.84 percentage points lower than the US Biotechnology industry revenue growth rate of 511.06%. Clearside Biomedical's revenue in the past year totaled $1.66 million.

How much does Clearside Biomedical make in a year?

Clearside Biomedical's revenue by year for the past five years is:
  • Clearside Biomedical's revenue for the twelve months ending Dec 31, 2024 was $1.66 million, a 79.77% decrease year over year.
  • Clearside Biomedical's annual revenue for Dec 31, 2023 was $8.23 million, a 519.89% increase from 2022.
  • Clearside Biomedical's annual revenue for 2022 was $1.33 million, a 95.51% decrease from 2021.
  • Clearside Biomedical's annual revenue for 2021 was $29.58 million, a 274.65% increase from 2020.
  • Clearside Biomedical's annual revenue for 2020 was $7.89 million, a 263.28% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.